Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Austar Lifesciences Ltd. ( (HK:6118) ) has provided an announcement.
Austar Lifesciences Limited, a company incorporated in the Cayman Islands, has announced an update to its board of directors and their roles, effective from August 26, 2025. The board comprises executive, non-executive, and independent non-executive directors, with Mr. Ho Kwok Keung, Mars serving as the Chairman and CEO. The announcement also details the membership of five board committees, highlighting the leadership and participation of each director in these committees.
The most recent analyst rating on (HK:6118) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Austar Lifesciences Ltd. stock, see the HK:6118 Stock Forecast page.
More about Austar Lifesciences Ltd.
Average Trading Volume: 1,446,466
Technical Sentiment Signal: Buy
Current Market Cap: HK$676.6M
For a thorough assessment of 6118 stock, go to TipRanks’ Stock Analysis page.